(CercleFinance.com) – OSE Immunotherapeutics announces the appointment of Laurence de Schoulepnikoff to the post of Chief BusinessOfficer (CBO).
With more than 25 years of experience, Laurence de Schoulepnikoff has notably worked at AMALTherapeutics, FerringInternational, StragenPharma SA as well as in large organizations (Business Development at Novartis).
OSEImmunotherapeutics also announces the appointment of three senior directors to strengthen its development team: Linda Lebon is appointed to the post of Director of Regulatory Affairs, Silvia Comis to the post of Director of Clinical Development and Françoise Bono to the post of Director of Strategic Development.